Français
ItalianoBond Royalty Pharma 5.95% ( US78081BAV53 ) in USD
| Issuer | Royalty Pharma | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  United States
|
||||
| ISIN code |
 US78081BAV53 ( in USD )
|
||||
| Interest rate | 5.95% per year ( payment 2 times a year) | ||||
| Maturity | 25/09/2055 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 78081BAV5 | ||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||
| Next Coupon | 25/09/2026 ( In 9 days ) | ||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, pays a coupon of 5.95% per year. The coupons are paid 2 times per year and the Bond maturity is 25/09/2055 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||